Geneoscopy closes $105 M in Series C funding round to power next-generation of gastrointestinal diagnostic tests

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million.

Lilly backs OrsoBio’s $60M Series A for PhII trials in obesity and NASH

OrsoBio, a biotech focused on obesity and metabolic disorders, is getting financial support from one of the leading drugmakers in the field as Eli Lilly

November 8, 2023

Uterine Cancer Trials Made Waves This Year, Experts Say

Results from two phase III trials — NRG-GY018 and RUBY — presented earlier this year at the Society of Gynecologic Oncology (SGO) annual meeting demonstrated

November 23, 2023

Lykos’ pain is others’ gain as psychedelic biotechs take notes from adcomm vote

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.